Hypomethylating agents combined with low-dose chemotherapy for elderly patients with acute myeloid leukaemia unfit for intensive chemotherapy: a real-world clinical experience-Reference-Cited by-同舟云学术

Hypomethylating agents combined with low-dose chemotherapy for elderly patients with acute myeloid leukaemia unfit for intensive chemotherapy: a real-world clinical experience

Published:2022-07-26 Issue: Volume: Page:1-8
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Chen Yi,Cao Jing¹,Ye Yaozhen¹,Luo Luting¹,Zheng Xiaoyun¹,Yang Xiaozhu¹,Zheng Zhihong¹,Zheng Jing¹,Yang Ting¹,Hu Jianda¹

Affiliation:

1. Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fuzhou, China

Funder

Startup Fund for scientific research, Fujian Medical University

Construction project of Fujian medical center of hematology

National Natural Science Foundation of China

National Key Clinical Specialty Discipline Construction Program

Fujian Provincial Clinical Research Center for Hematological Malignancies

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2022.2097433

Reference33 articles.

1. Cancer statistics, 2020

2. Survival for older patients with acute myeloid leukemia: a population-based study

3. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

4. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

5. Acute myeloid leukemia in the elderly: therapeutic options and choice

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of venetoclax for the treatment of unfit AML patients in real-world: is all that glitters gold?;Annals of Hematology;2024-08-16